PhD - Molecular Neurodegeneration in human brain tissue

The project is embedded in the research program of Prof Dr Annelies Quaegebeur at the Translational Cell and Tissue Research Unit of the department of Imaging & Pathology, KU Leuven, with strong ties to the University of Cambridge. The lab is focused on the toxic interaction between protein aggregation, glia-mediated inflammation and neurodegeneration. We are an international, interdisciplinary team integrated in extensive international networks such as Aligning Science Across Parkinson's (ASAP) and Dementia Frontiers Fund.
We study disease directly in the human context: by direct access to deeply phenotyped human post-mortem brain tissues, we move beyond animal and cell-based models to interrogate the molecular landscape of neurodegeneration as it actually unfolds in human disease.

Project

We are seeking a highly motivated PhD candidate to help build a molecular, spatial picture of how glia contribute to neurodegeneration in the human brain.
Glia are emerging as a promising therapeutic avenue in neurodegenerative disease but a deeper molecular understanding is needed. The successful candidate will investigate the molecular signatures of glia in human brain tissue of Lewy Body pathologies and tauopathies. The work will focus on characterising glial states through an integrated approach of cutting-edge spatial proteomic and histological technologies.

Profile

Essential requirements:
·       A Master's degree in Biomedical Sciences, Medicine, Biochemistry, (Neuro)biology, Cell/Molecular Biology, or a closely related field.
·       Critical thinking, with the ability to design experiments, analyse data rigorously, and troubleshoot proactively.
·       Interested in molecular mechanisms of neurodegeneration.
·       Enthusiasm for learning innovative technologies and working with human brain tissue.
·       Good written and verbal communication skills and fluency in English.
·       Rigorous, organised, and collaborative, with enthusiasm for working in an international, interdisciplinary environment.
Bonus:
·       Hands-on experience with histology and/or tissue-based techniques (e.g. immunohistochemistry, immunofluorescence, microscopy, image analysis software).
·       Experience with mass spectrometry and/or proteomics workflows and data.
·       Familiarity with data analysis tools (e.g. Python, R).

Offer

·       At least 1 year of funding, with support to obtain PhD fellowship funding for the remainder of the doctoral trajectory.
·       You will become an integral part of a dynamic, well-funded research group, with strong ties to the University of Cambridge, utilising advanced technologies and able to support ambitious research projects.
·       You will work with cutting-edge spatial proteomics technology, expertise, and infrastructure that offers a novel window onto glia in the human brain.
·       You will be trained in working with human brain tissue, a specialised, highly sought-after expertise that will set you apart on the scientific job market.
·       Access to unique collections of deeply phenotyped human brain tissue of neurodegeneration.
·       You will be co-supervised by experts from the Laboratory of Applied Mass Spectrometry - Metabolomics expertise center.
·       You will join a collaborative team with English as the working language, and benefit from an extensive network of international scientific collaborators and opportunities for career development
·       A high degree of autonomy in designing and executing experiments, with a flexible schedule supporting a healthy work-life balance.
·       Enrollment in a structured university doctoral training programme offering comprehensive training to broaden your expertise and enhance your professional skill set.

Interested?

For more information please contact Prof Dr Annelies Quaegebeur: [email protected]

To apply, please submit:
- Motivation letter
- Curriculum vitae
- Academic transcripts
- Contact details of two academic referees

The anticipated start date is 1st of October 2026

KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.